INNO LIA HCV SCORE Test (Immunoblot)

Confirmation of Hepatitis C virus infection by an immunoblot test.

Serum or plasma sample. Minimum volume required for serum or plasma – 0.5 mL.

Collect blood in serum separator tubes (SST) or EDTA tubes.

Store samples refrigerated or frozen until shipped for testing. Ship frozen samples on dry ice, and refrigerated samples on wet ice

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

Suspected Hepatitis C infection. Anti-HCV must be positive on screening with an EIA test.

Completed Molecular and Immuno Diagnostics on Hepatitis requisition form including sender name, address and telephone number. Patient name or identifier (referring specimen lab #), date of birth, suspected exposure, test(s) requested. Type of specimen and date collected. If possible, include the clinical history and lab results that have already been done at local or provincial laboratories.

This is a supplemental test used for confirmation of anti-HCV positive result upon screening with an EIA test.

28 calendar days.

1. Berger A, Rabenau H, Allwinn R, Doerr HW. Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions. J Clin Virol. 2008 Oct;43(2):158-61.
2. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology. 2002 Nov;36(5 Suppl 1):S65-73.